In addition, p21-activated kinase 1 (PAK1), an oncogene involved in activation of MAP kinase and MET signaling, was identified as a potential target of miR-494, with an inverse correlation with the miRNA and partial reversal of the tumor-inhibitory effects seen when PAK1 was re-expressed [26]. The gene discussed is PAK1; the disease is neoplasm.